Thienopyridine Agents and Patent Foramen Ovale Closures Reduce Migraines

Investigators reviewed past studies to find evidence that P2Y12 inhibitors effectively improve migraine headache symptoms.

Source link

Related posts

Primary Periodic Paralysis 101


Benefits of Switching to Tenecteplase for Stroke Thrombolysis


Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World